Advances in the treatment of Clostridium difficile with fidaxomicin: a narrow spectrum antibiotic

Clostridium difficile infection, also known as C. difficile‐associated diarrhea (CDAD), is the most common cause of nosocomial diarrhea, typically initiated by the use of broad‐spectrum antibiotics that disrupt gut flora, thereby allowing C. difficile to proliferate. It is an increasing cause of mor...

Ausführliche Beschreibung